We are live on ! Find out more
ELAN icon

Elanco Animal Health

452 hedge funds and large institutions have $14.9B invested in Elanco Animal Health in 2021 Q3 according to their latest regulatory filings, with 52 funds opening new positions, 175 increasing their positions, 141 reducing their positions, and 74 closing their positions.

New
Increased
Maintained
Reduced
Closed

69% more call options, than puts

Call options by funds: $57.9M | Put options by funds: $34.2M

24% more repeat investments, than reductions

Existing positions increased: 175 | Existing positions reduced: 141

0% more funds holding in top 10

Funds holding in top 10: 1111 (0)

0.08% less ownership

Funds ownership: 99.07%98.99% (-0.08%)

5% less funds holding

Funds holding: 478452 (-26)

8% less capital invested

Capital invested by funds: $16.2B → $14.9B (-$1.31B)

30% less first-time investments, than exits

New positions opened: 52 | Existing positions closed: 74

Holders
452
Holders Change
-26
Holders Change %
-5.44%
% of All Funds
7.91%
Holding in Top 10
11
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.19%
New
52
Increased
175
Reduced
141
Closed
74
Calls
$57.9M
Puts
$34.2M
Net Calls
+$23.7M
Net Calls Change
+$26.1M
Name Holding Trade Value Shares
Change
Change in
Stake
Balyasny Asset Management
451
Balyasny Asset Management
Illinois
-$18.6M -535,874 Closed
Marshall Wace
452
Marshall Wace
United Kingdom
-$18.1M -522,823 Closed
IG
453
ING Group
Netherlands
-$9.54M -275,000 Closed
BAM
454
Blueshift Asset Management
New Jersey
-$8.55M -246,372 Closed
PP
455
Paloma Partners
Connecticut
-$8.51M -245,313 Closed
WP
456
Woodline Partners
California
-$4.73M -136,322 Closed
Voloridge Investment Management
457
Voloridge Investment Management
Florida
-$4.35M -125,390 Closed
SEC
458
Seven Eight Capital
New York
-$3.87M -111,560 Closed
SSA
459
Schonfeld Strategic Advisors
New York
-$2.89M -83,468 Closed
SFI
460
Susquehanna Fundamental Investments
Pennsylvania
-$2.46M -70,900 Closed
OQS
461
Occudo Quantitative Strategies
Florida
-$2.4M -69,062 Closed
AF
462
Alerus Financial
North Dakota
-$2.06M -59,341 Closed
Qube Research & Technologies (QRT)
463
Qube Research & Technologies (QRT)
United Kingdom
-$1.99M -57,265 Closed
AFM
464
Anson Funds Management
Texas
-$1.74M -50,000 Closed
LPARFS
465
Leverage Partners Absolute Return Fund SPC
Cayman Islands
-$1.21M -35,000 Closed
DA
466
Duality Advisers
Florida
-$1.19M -34,306 Closed
QT
467
Quantbot Technologies
New York
-$1.13M -32,517 Closed
PP
468
Prudential plc
United Kingdom
-$1.13M -32,470 Closed
KAS
469
Kemnay Advisory Services
New York
-$789K -22,757 Closed
BPC
470
Banque Pictet & Cie
Switzerland
-$590K -17,000 Closed
BCM
471
Brasada Capital Management
Texas
-$590K -17,000 Closed
Tudor Investment Corp
472
Tudor Investment Corp
Connecticut
-$542K -16,158 Closed
PRC
473
Pearl River Capital
Michigan
-$559K -16,103 Closed
QC
474
Quadrature Capital
United Kingdom
-$547K -15,770 Closed
LFM
475
Lumina Fund Management
New York
-$520K -15,000 Closed

ELAN Hedge Fund Activity: Q3 2021 in Review

452 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Elanco Animal Health (ELAN) for Q3 2021, worth a combined $14.9B — down 8.1% from $16.2B a quarter earlier.

Sellers outnumbered buyers: 74 funds closed out of ELAN and 52 opened new positions — a net loss of 22 holders — while 141 trimmed existing stakes and 175 added.

The largest buyer was Franklin Resources, adding an estimated $160M. The largest seller was Janus Henderson Group, cutting an estimated $236M.

  • 452 institutional investors held Elanco Animal Health (ELAN) as of Q3 2021, down from 478 in Q2 2021.
  • Funds reported $14.9B of Elanco Animal Health stock for Q3 2021, down 8.1% quarter-over-quarter.
  • 52 funds opened new Elanco Animal Health positions in Q3 2021 and 74 closed out, a net change of -22 holders.
  • The largest Elanco Animal Health buyer in Q3 2021 was Franklin Resources, an estimated $160M added.
  • The largest Elanco Animal Health seller in Q3 2021 was Janus Henderson Group, an estimated $236M sold.

Based on aggregated 13F filings for Q3 2021.